CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Quarterly Update & Appendix 4C, page-140

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. pierre23
    2,977 Posts.
    lightbulb Created with Sketch. 1464
    clock Created with Sketch.
    05/08/21
    22:27
    Post #: 55069215
    Ouch... I guess you're one of the culprits who snap up the shares when they eventually get dumped. Good luck.
    CPH Price at posting: 12.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.